Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3',5'-cyclic monophosphate degradation.

THE PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY

1963 • 10,322 citations

Antibodies to major histocompatibility antigens produced by hybrid cell lines

1977 • 1,727 citations

A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor

1989 • 996 citations

Cyclic GMP synthesis and function.

1987 • 871 citations

Studies on the Mechanism of Hormone Action

1972 • 682 citations

Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues.

1984 • 676 citations

Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.

1984 • 495 citations

Atriopeptin: A Cardiac Hormone Intimately Involved in Fluid, Electrolyte, and Blood-Pressure Homeostasis

1986 • 491 citations

Release of natriuretic factor from rat heart-lung preparation by atrial distension

1984 • 341 citations

The increase of cGMP by atrial natriuretic factor correlates with the distribution of particulate guanylate cyclase

1985 • 228 citations

Atrial Natriuretic Peptide Inhibits a Cation Channel in Renal Inner Medullary Collecting Duct Cells

1989 • 228 citations

[7] The use of carbodiimides in the preparation of immunizing conjugates

1980 • 197 citations

Endothelium‐derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells

1988 • 130 citations

Renal and systemic effects of synthetic atrial natriuretic factor

1985 • 124 citations

cGMP mediates effects of atrial peptides on medullary collecting duct cells

1987 • 104 citations

Inhibition of aldosterone production by α-human atrial natriuretic polypeptide is associated with an increase in cGMP production

1985 • 99 citations

The Renal Response to Acute Hypervolemia is Caused by Atrial Natriuretic Peptides

1986 • 94 citations

In vivo evidence that cGMP is the second messenger for atrial natriuretic factor.

1986 • 86 citations

Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis

1986 • 78 citations

Effects of antiallergic agents, compound 48/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate phosphodiesterases.

1977 • 76 citations

Development, validation and application of an enzyme immunoassay (EIA) of atriopeptin

1987 • 71 citations

Urinary cGMP as biological marker of the renal activity of atrial natriuretic factor

1988 • 69 citations

Guanosine 3',5'-cyclic monophosphate as a mediator of inhibition of renin release

1988 • 61 citations

Atrial natriuretic factor decreases whole-body capillary absorption in rats

1987 • 42 citations

Role of atrial natriuretic factor, cyclic GMP and the renin–aldosterone system in acute volume regulation of healthy human subjects

1988 • 31 citations

The elevation of cyclic GMP as a response to acute hypervolemia is blocked by a monoclonal antibody directed against atrial natriuretic peptides

1986 • 30 citations

Effects of antiserum against alpha-rat atrial natriuretic peptide in anesthetized rats.

1987 • 23 citations

Dissociation of natriuresis and diuresis and heterogeneity of the effector system of atrial natriuretic factor in rats.

1989 • 20 citations

Atriopeptin II‐induced relaxation of rabbit aorta is potentiated by M&B 22,948 but not blocked by haemoglobin

1986 • 18 citations

Small intestine as possible source of increased plasma cGMP after administration of alpha-hANP to dogs

1988 • 11 citations

Urinary guanosine 3′: 5′-cyclic monophosphate but not tissue kallikrein follows the plasma atrial natriuretic factor response to acute volume expansion with saline

1988 • 11 citations